Project Grant RF1AG079324
Award Date
9/10/22
Completion Date
8/31/25
Dollars Obligated
$4.6M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
The National Institute on Aging awarded Emory University a $2,340,263 Project Grant (CFDA 93.866) to develop machine learning-based predictive models for post-stroke cognitive impairment (PSCI) using routine clinical and imaging data. The project aims to 1) learn to predict PSCI from large clinical datasets, 2) validate the models using prospective data, and 3) characterize PSCI biology and physiology one year post-stroke. Emory University will collaborate with the University of Kansas Medical...
This $780,466 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research to develop digital biomarkers for detecting pathological brain aging and early stages of neurodegeneration associated with Alzheimer's disease. The project aims to leverage single-channel sleep electroencephalography (EEG) recorded from wearable headband devices to build machine learning models that can quantify the integrity of sleep-dependent memory processing...
This National Institute on Aging (NIA) Project Grant award, funded under the Aging Research program (CFDA 93.866), will develop machine learning-based electroencephalogram (EEG) biomarkers to predict and monitor the risk of dementia in older adults. The $134,730 award, with a period of performance from July 2024 to June 2026, will be conducted by the General Hospital Corporation (Massachusetts General Hospital). The project aims to leverage deep learning techniques to extract novel EEG...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will provide $834,094 to The University of Texas Southwestern Medical Center to conduct research on post-stroke cognitive impairment and dementia. The award period is from September 15, 2024 to July 31, 2029. The key objectives of this project are to determine the incidence and prevalence of post-stroke cognitive impairment and dementia, identify associated risk factors, and evaluate...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $198,976 to The Johns Hopkins University to develop AI-driven methods for assessing physical and cognitive digital biosignals in frail older adults, including those with Alzheimer's disease. The research aims to associate these biometric data with molecular markers to enhance understanding of the varied characteristics of frailty and early cognitive changes in aging populations. The award...
This $4.46 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866) to develop a new in vivo magnetic resonance imaging biomarker for early detection of Alzheimer's disease neurodegeneration. Specifically, the awardee, Washington University, will utilize quantitative gradient recalled echo MRI techniques to identify two types of hippocampal tissue in preclinical and mild...
This $454,225 Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) will support research at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop new methods for assessing "effective reserve" in patients with acute ischemic stroke. The key objectives are to: 1) investigate the concept of effective reserve and its feasibility in acute ischemic stroke patients using two large...
This federal Project Grant award for $108,105.00, provided by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to investigate the potential of transcranial direct current stimulation (tDCS) as a therapeutic intervention to improve neurovascular coupling and cognitive function in stroke survivors with post-stroke cognitive impairment (PSCI). The project has two key objectives: 1) to comprehensively evaluate neurovascular coupling responses in stroke survivors...
The Johns Hopkins University was awarded a $2,399,582 Project Grant from the National Institute on Aging (CFDA 93.866 Aging Research) to study extracellular vesicles derived from the brain as potential biomarkers for Alzheimer's disease. The 3-year grant, which begins on September 1, 2023, aims to identify specific cell surface markers and molecular signatures on brain-derived extracellular vesicles that could be used for early disease detection, monitoring, and understanding Alzheimer's...
This federal Project Grant award, valued at $2,399,431 and effective August 1, 2024, is funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The objective is to develop a digital cognitive health resource based on the Boston University Alzheimer's Disease Research Center (BU ADRC) cohort. The grant will leverage the BU ADRC's extensive longitudinal data, including vascular risk factors, biomarkers, and neuropsychological tests, to collect concurrent...